Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(3):164-165; doi:10.1093/jnci/97.3.164
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Schmidt, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Without More Federal Support, Success of U.S. Stem Cell Research Questioned

Charles Schmidt

The first 150 words of the full text of this article appear below.

In the absence of broader federal support, alternate funding sources are taking the lead in promoting embryonic stem (ES) cell research in the United States. During the last year, Stanford and Harvard universities have launched multimillion-dollar ES cell programs with private funds, while California taxpayers authorized Proposition 71, a $3 billion, 10-year effort to advance the field's medical goals. States including Wisconsin, Illinois, Florida, New Jersey, and Massachusetts are now considering their own stem cell programs, hoping to secure a foothold in this growing field of research.

As the main backers of stem cell science, these entities complement the National Institutes of Health, whose $28 billion annual budget supports most of the basic biomedical research in this country today. The NIH is a minor player in the field, however, committing just $24 million to ES cell research in 2004. Constrained by Bush administration policy, NIH-funded scientists are limited to studying . . . [Full Text of this Article]

Varying Attitudes

Short-Term Implications?

Funding Challenges

Moving Forward


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?